Pep®-Sensyl (Acetyl Tetrapeptide-15)
- Product Code: 31067
It was developed with the aim of reducing skin hypersensitivity (reduced skin sensitivity), causing chronic inflammation and neuropathic pain, through the process of stimulating neurons in μ-opioid receptors.
It was developed with the aim of reducing skin hypersensitivity (reduced skin sensitivity), causing chronic inflammation and neuropathic pain, through the process of stimulating neurons in μ-opioid receptors.
Pep®-Sensyl is Acetyl Tetrapeptide-15 in water-soluble powder form, containing a Peptide concentration of 1500ppm.
Acetyl Tetrapeptide-15 in concentrations of 1350-1500ppm is often traded under the name Skinasensyl.
Acetyl tetrapeptide-15 is a peptide sequence derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist. It has a skin desensitizing effect, thus reducing allergies and skin irritation. It is commonly used in products to reduce irritation, allergies and skin sensitivity.
Acetyl tetrapeptide-15 was developed with the aim of reducing skin hyperreactivity (decreased skin sensitivity) causing chronic inflammation and neuropathic pain through the activation of neurons in μ-opioid receptors.
The efficacy of this peptide has been demonstrated both in vitro and on real skin, with acetyl tetrapeptide-15 being tested for its ability to modulate CGRP release. CGRP is released following TRVP1 activation by Capsaisin.
The test was performed by incubating sensory neurons with acetyl tetrapeptide-15 (0.0003% and 0.001%), capsazepine (10 μM, a TRPV1 antagonist), or verapamil (100 μM, a calcium channel blocker) for 6 h and then exposing them to KCl and capsaicin. It was found that 0.001% acetyl tetrapeptide-15 significantly reduced CGRP release when neurons were exposed to both capsaicin and KCl, more effectively than 10 μM capsazepine.
A blinded clinical study demonstrated the ability of acetyl tetrapeptide-15 to reduce skin sensitivity following capsaicin exposure in 20 subjects. The protocol began by applying increasing concentrations of capsaicin solution intranasally to determine the concentration that produced discomfort. Then, a 0.0015% solution containing acetyl tetrapeptide-15 was applied twice daily for four days, and the application was repeated to increase the capsaicin concentration. Overall, there was a significant increase in the capsaicin threshold, demonstrating its efficacy.
Various research studies have confirmed that Acetyl tetrapeptide-15 can help reduce skin sensitivity, making it suitable for use in formulas that require reducing skin irritation.
Usage: For products that reduce skin irritation.
Mixing method: Mix in the final step. Avoid heat. Can be dissolved in water.
Usage rate: 0.3-1%
Product appearance: white powder
Solubility: Can be dissolved in water.
Storage: For long-term storage, keep refrigerated. Avoid exposure to sunlight and heat. Seal the lid tightly.
INCI Name : Mannitol (and) Sodium Citrate (and) Acetyl Tetrapeptide-15
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Cart
No products